Uma candidatura completa num minuto — currículo personalizado e carta de apresentação, prontos a enviar.
Universidade do Minho invites applications for a Principal Investigator position in Medical Biotechnology within the 3B's Research Group of the I3Bs Organic Unit. The appointment is permanent and full-time, open through an international competition, and aims to advance cutting-edge research in cellular, tissue, and organ technologies.
The successful candidate will lead high-impact investigations under a private-law contract, contributing to the University’s strategic goals in biotechnology and
Organisation/Company University of Minho Department Unidade Orgânica I3's Research Field Technology Biotechnology Researcher Profile Leading Researcher (R4) Positions PhD Positions Application Deadline 20 Oct *********:59 (Europe/Brussels) Country Portugal Type of Contract Permanent Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description
It is made public that an international document-based competition is open for the recruitment, under a permanent employment contract under private law, of 1 (one) position of Principal Investigator in the scientific area of Medical Biotechnology in the subarea of Technologies involving the manipulation of Cells, Tissues, Organs, or the whole Organism, within the 3B's Research Group of the I3Bs Organic Unit at this University.
Requirements
Research Field Technology Biotechnology Education Level PhD or equivalent Skills/Qualifications Details described in the job description section.
Specific Requirements Details Described In The Job Description Section.
I3BS-******** - Edital - PT - I3BS_**********_signed.Pdf I3BS-******** - Edital - EN - I3BS_**********_signed.Pdf Details described in the job description section.
Eligibility Criteria Details Described In The Job Description Section.
Selection process Details described in the job description section.
Additional comments